Stemcell and Regenerative Medicine
Contact us
February 26, 2025   09:00 AM GMT

International Webinar onStemcell and Regenerative Medicine

Early Bird Registration End Date: Jan 31, 2025
Abstract Submission Opens: Dec 02, 2024

Get In Touch

Latest News

The Alarm's Mike Peters Seeks Stem Cell Donor Amid Health Battle

2024-12-19 - 2024-12

Content: Mike Peters, lead singer of the rock band The Alarm, is urgently searching for a stem cell donor after being diagnosed with Richter's syndrome, a transformation of chronic lymphocytic leukemia into an aggressive lymphoma. Peters has launched the "One in a Million" campaign through the Love Hope Strength foundation to find a matching donor. Despite his health challenges, Peters remains hopeful and continues to engage with his music, recently releasing a new music video.

Mesoblast's Stem Cell Therapy Approved for Pediatric GVHD

2024-12-20 - 2024-12

Biotech company Mesoblast has received FDA approval for Ryoncil, the first treatment for children with acute graft versus host disease (GVHD) unresponsive to steroids. This approval marks a significant advancement in cell therapy, offering a new treatment option for a condition affecting many bone-marrow transplant patients.

U.S. Stem Cell Therapy Market Revenue to Attain USD 17.70 Bn by 2033

2024-12-26 - 2024-12

U.S. Stem Cell Therapy Market Revenue and Trends 2023 to 2033
The U.S. stem cell therapy market revenue surpassed USD 5.99 billion in 2024 and is predicted to attain around USD 17.70 billion by 2033, growing at a CAGR of 12.79%. The rising prevalence of chronic diseases and innovations in stem cell-based therapies drive the growth of the market.

U.S. Stem Cell Therapy Market Statistics

Market Overview
Stem cell therapy is an ideal approach to eliminate generative deficiencies by replacing diseased cells. It replaces tissue or organs damaged by age, disease, or injuries. Stem cells have the ability to regenerate new tissues in the human body and, hence, are mostly used for therapeutic purposes in tissue regeneration and repair.

The U.S. stem cell therapy market has been witnessing rapid growth due to the increasing cases of osteoarthritis and musculoskeletal diseases. Stem cell therapy has the potential to heal wounds and is also under development for treating diseases like rheumatoid arthritis, Crohn's disease, and multiple sclerosis. In addition, the increasing funding by private and commercial sectors in stem cell therapy and innovations in technologies like 3D printing propel the market for U.S. stem cell therapy. The rising demand for personalized therapies that possess fewer side effects on the patients and the increasing use of CRISPR technology further contribute to market expansion.

Useful Links

Subscribe Now